- PR Newswire•21 hours agoPhilips receives FDA 510(k) clearance to market its ElastQ Imaging shear wave elastography for non-invasive assessment of tissue stiffness of the liver
AMSTERDAM, Feb. 27, 2017 /PRNewswire/ -- Royal Philips (NYSE:PHG AEX: PHIA), a global leader in health technology, today announced 510(k) clearance from the U.S. Food and Drug Administration (FDA) to ...
- Business Wire•6 days agoPhilips Reinforces Leadership in Image-Guided Therapy Solutions with Global Launch of Next Generation Azurion Platform
Royal Philips , a leader in health technology, today announced the global launch of Azurion, its next generation image-guided therapy platform, which forms the new core of its integrated solutions portfolio for the fast growing image-guided therapy market.
- Business Wire•6 days agoPhilips Joins the Mackenzie Innovation Institute (Mi2) Mission to Develop Disruptive Innovations and Solutions That Improve Patient Care
Royal Philips today announced that it is partnering with the Mackenzie Innovation Institute in Canada on opportunities to develop, test and evaluate technological solutions and innovations intended to improve patient care across the healthcare system.
PHG : Summary for Koninklijke Philips N.V. NY Reg - Yahoo Finance
Koninklijke Philips N.V. (PHG)
NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
|Day's Range||29.81 - 30.14|
|52 Week Range||23.00 - 30.79|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||18.10|
|Dividend & Yield||0.86 (2.91%)|
|1y Target Est||N/A|